BACKGROUND: Our interest in immunological effects produced by vitamin D(3) (1,25(OH)(2)D(3)) and its therapeutic potential prompted us to examine the role of 1,25(OH)(2)D(3) on cytokine production by Candida albicans. METHODS: Peripheral blood mononuclear cells (PBMC) with stimulated C. albicans and 1,25(OH)(2)D(3), cytokine concentrations were measured in supernatant. Quantitative polymerase chain reaction (qPCR) was performed for T cell transcription factors, SOCS1 and 3. TLR2/4, Dectin-1, and mannose receptor expression was studied using flow cytometry and qPCR. An ex-vivo stimulation study was carried out in healthy volunteers to investigate the seasonality of immune response to C. albicans. RESULTS: Upon in vitro C. albicans stimulation, 1,25(OH)(2)D(3) induced a dose-dependent, down-regulation of IL-6, TNFα, IL-17, and IFNγ. It also increased IL-10 production. The shift in cytokine profile was not due to 1,25(OH)(2)D(3) augmenting expression of either Thelper differentiation factors or SOCS1 and SOCS3 mRNA. 1,25(OH)(2)D(3) inhibited TLR2, TLR4, Dectin-1, and MR mRNA and protein expression. In our seasonality study, both IL-17 and IFNγ levels were suppressed in summer when 25(OH)D(3) levels were elevated. CONCLUSION: Vitamin D(3) skews cytokine responses toward an antiinflammatory profile, mediated by suppression of TLR2, TLR4, Dectin-1, and MR transcription, leading to reduced surface expression. The biological relevance of these effects has been confirmed by the seasonality of cytokine responses.
BACKGROUND: Our interest in immunological effects produced by vitamin D(3) (1,25(OH)(2)D(3)) and its therapeutic potential prompted us to examine the role of 1,25(OH)(2)D(3) on cytokine production by Candida albicans. METHODS: Peripheral blood mononuclear cells (PBMC) with stimulated C. albicans and 1,25(OH)(2)D(3), cytokine concentrations were measured in supernatant. Quantitative polymerase chain reaction (qPCR) was performed for T cell transcription factors, SOCS1 and 3. TLR2/4, Dectin-1, and mannose receptor expression was studied using flow cytometry and qPCR. An ex-vivo stimulation study was carried out in healthy volunteers to investigate the seasonality of immune response to C. albicans. RESULTS: Upon in vitro C. albicans stimulation, 1,25(OH)(2)D(3) induced a dose-dependent, down-regulation of IL-6, TNFα, IL-17, and IFNγ. It also increased IL-10 production. The shift in cytokine profile was not due to 1,25(OH)(2)D(3) augmenting expression of either Thelper differentiation factors or SOCS1 and SOCS3 mRNA. 1,25(OH)(2)D(3) inhibited TLR2, TLR4, Dectin-1, and MR mRNA and protein expression. In our seasonality study, both IL-17 and IFNγ levels were suppressed in summer when 25(OH)D(3) levels were elevated. CONCLUSION:Vitamin D(3) skews cytokine responses toward an antiinflammatory profile, mediated by suppression of TLR2, TLR4, Dectin-1, and MR transcription, leading to reduced surface expression. The biological relevance of these effects has been confirmed by the seasonality of cytokine responses.
Authors: L Overbergh; B Decallonne; M Waer; O Rutgeerts; D Valckx; K M Casteels; J Laureys; R Bouillon; C Mathieu Journal: Diabetes Date: 2000-08 Impact factor: 9.461
Authors: M Hirschfeld; J J Weis; V Toshchakov; C A Salkowski; M J Cody; D C Ward; N Qureshi; S M Michalek; S N Vogel Journal: Infect Immun Date: 2001-03 Impact factor: 3.441
Authors: Mihai G Netea; Neil A R Gow; Leo A B Joosten; Ineke Verschueren; Jos W M van der Meer; Bart Jan Kullberg Journal: Med Mycol Date: 2010-11 Impact factor: 4.076
Authors: Frank L van de Veerdonk; Renoud J Marijnissen; Bart Jan Kullberg; Hans J P M Koenen; Shih-Chin Cheng; Irma Joosten; Wim B van den Berg; David L Williams; Jos W M van der Meer; Leo A B Joosten; Mihai G Netea Journal: Cell Host Microbe Date: 2009-04-23 Impact factor: 21.023
Authors: Joost Smolders; Mariëlle Thewissen; Evelyn Peelen; Paul Menheere; Jan Willem Cohen Tervaert; Jan Damoiseaux; Raymond Hupperts Journal: PLoS One Date: 2009-08-13 Impact factor: 3.240
Authors: N Dauletbaev; K Herscovitch; M Das; H Chen; J Bernier; E Matouk; J Bérubé; S Rousseau; L C Lands Journal: Br J Pharmacol Date: 2015-10 Impact factor: 8.739
Authors: Tyler Barker; Thomas B Martins; Harry R Hill; Carl R Kjeldsberg; Brian M Dixon; Erik D Schneider; Vanessa T Henriksen; Lindell K Weaver Journal: Eur J Appl Physiol Date: 2013-01-06 Impact factor: 3.078
Authors: John Gubatan; Shuji Mitsuhashi; Maria Serena Longhi; Talia Zenlea; Laura Rosenberg; Simon Robson; Alan C Moss Journal: Cytokine Date: 2018-01-08 Impact factor: 3.861
Authors: A-L Khoo; L Y A Chai; H J P M Koenen; F C G J Sweep; I Joosten; M G Netea; A J A M van der Ven Journal: Clin Exp Immunol Date: 2011-02-16 Impact factor: 4.330
Authors: M Kox; M J W van den Berg; J G van der Hoeven; J P M Wielders; A J van der Ven; P Pickkers Journal: Clin Exp Immunol Date: 2013-02 Impact factor: 4.330